|
Mechanismμ opioid receptor inverse agonists |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date12 Dec 2003 |
100 Clinical Results associated with Qinghai Pharmaceutical (Group) Co., Ltd.
0 Patents (Medical) associated with Qinghai Pharmaceutical (Group) Co., Ltd.
100 Deals associated with Qinghai Pharmaceutical (Group) Co., Ltd.
100 Translational Medicine associated with Qinghai Pharmaceutical (Group) Co., Ltd.